GreenLight Biosciences (GRNA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    GreenLight Biosciences

    NASDAQ: GRNA · Real-Time Price · USD
    0.30
    0.00 (0.13%)
    At close: Jul 21, 2023, 10:00 PM

    GreenLight Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Cash & Equivalents
    		 32.35M 68.1M 98.35M 44.13M 83.22M 67.5K 34.75M 97.38K 197.47K
    Short-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a 207.01M n/a
    Other Long-Term Assets
    		 2.81M 3.16M 3.16M 2.72M 2.61M 207.01M 4.01M n/a 207M
    Receivables
    		 n/a n/a n/a 10M 5M n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Current Assets
    		 5.35M 3.21M 10.95M 9.87M 8.72M n/a n/a 835.47K 924.6K
    Total Current Assets
    		 37.7M 71.31M 109.31M 64M 96.95M 530.05K 37.53M 932.85K 1.12M
    Property-Plant & Equipment
    		 73.18M 74.13M 38.95M 32.09M 22.88M n/a 21.74M n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 75.99M 77.29M 42.11M 34.81M 25.48M 207.01M 25.76M 207.01M 207M
    Total Assets
    		 113.69M 148.6M 151.42M 98.81M 122.43M 207.54M 63.29M 207.94M 208.12M
    Account Payables
    		 1.07M 839K 3.03M 4.16M 6.05M 11.7M 6.56M n/a n/a
    Deferred Revenue
    		 47K 3.87M 7.36M 8.94M 3.94M n/a 1.38M n/a n/a
    Short-Term Debt
    		 17.86M 16.59M 12.91M 11.4M 9.85M 500K 23.8M n/a n/a
    Other Current Liabilities
    		 12.2M 14.27M 9.12M 30.72M 9.69M 118.57K 9.94M 1.16M 1.01M
    Total Current Liabilities
    		 31.19M 35.56M 32.42M 55.22M 29.52M 12.32M 41.68M 1.16M 1.01M
    Long-Term Debt
    		 59.56M 63.9M 16.77M 20.16M 23.69M n/a 15.01M n/a n/a
    Other Long-Term Liabilities
    		 1.01M 1.08M 17.81M 9.71M 3.63M n/a 221.44M 14.37M 11.67M
    Total Long-Term Liabilities
    		 60.57M 64.98M 34.59M 29.87M 29.08M 15.88M 236.45M 14.37M 11.67M
    Total Liabilities
    		 91.75M 100.54M 67M 85.08M 58.6M 28.21M 278.12M 15.52M 12.68M
    Total Debt
    		 77.42M 80.48M 29.68M 31.56M 33.53M 500K 38.82M n/a n/a
    Common Stock
    		 15K 15K 15K 13K 13K 207M 3K 187.42M 190.44M
    Retained Earnings
    		 -449.11M -420.64M -381.87M -343.72M -291.79M -27.66M -218.9M -1.98M 1.04M
    Comprehensive Income
    		 n/a n/a n/a n/a -122.43M n/a n/a n/a n/a
    Shareholders Equity
    		 21.94M 48.06M 84.42M 13.72M 63.83M 179.34M -214.83M 5M 5M
    Total Investments
    		 n/a n/a n/a n/a n/a n/a n/a 207.01M n/a

    Add to Watchlist